187 related articles for article (PubMed ID: 1373346)
1. Natural and synthetic antifibrinolytics in cardiac surgery.
Hardy JF; Desroches J
Can J Anaesth; 1992 Apr; 39(4):353-65. PubMed ID: 1373346
[TBL] [Abstract][Full Text] [Related]
2. Natural and synthetic antifibrinolytics in adult cardiac surgery: efficacy, effectiveness and efficiency.
Hardy JF; Bélisle S
Can J Anaesth; 1994 Nov; 41(11):1104-12. PubMed ID: 7530172
[TBL] [Abstract][Full Text] [Related]
3. Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.
Dietrich W; Spannagl M; Boehm J; Hauner K; Braun S; Schuster T; Busley R
Anesth Analg; 2008 Nov; 107(5):1469-78. PubMed ID: 18931201
[TBL] [Abstract][Full Text] [Related]
4. Prophylactic Use of Antifibrinolytics During Pediatric Cardiac Surgery With Cardiopulmonary Bypass on Postoperative Bleeding and Transfusion: A Systematic Review and Meta-Analysis.
Schertz K; Karam O; Demetres M; Mayadunna S; Faraoni D; Nellis ME
Pediatr Crit Care Med; 2022 Nov; 23(11):e517-e529. PubMed ID: 35997516
[TBL] [Abstract][Full Text] [Related]
5. Use of antifibrinolytics in pediatric cardiac surgery: Where are we now?
Faraoni D; Rahe C; Cybulski KA
Paediatr Anaesth; 2019 May; 29(5):435-440. PubMed ID: 30365221
[TBL] [Abstract][Full Text] [Related]
6. Tranexamic acid and aprotinin in low- and intermediate-risk cardiac surgery: a non-sponsored, double-blind, randomised, placebo-controlled trial.
Later AF; Maas JJ; Engbers FH; Versteegh MI; Bruggemans EF; Dion RA; Klautz RJ
Eur J Cardiothorac Surg; 2009 Aug; 36(2):322-9. PubMed ID: 19250838
[TBL] [Abstract][Full Text] [Related]
7. Tranexamic acid compared with high-dose aprotinin in primary elective heart operations: effects on perioperative bleeding and allogeneic transfusions.
Casati V; Guzzon D; Oppizzi M; Bellotti F; Franco A; Gerli C; Cossolini M; Torri G; Calori G; Benussi S; Alfieri O
J Thorac Cardiovasc Surg; 2000 Sep; 120(3):520-7. PubMed ID: 10962414
[TBL] [Abstract][Full Text] [Related]
8. Changes in coagulation patterns, blood loss and blood use after cardiopulmonary bypass: aprotinin vs tranexamic acid vs epsilon aminocaproic acid.
Menichetti A; Tritapepe L; Ruvolo G; Speziale G; Cogliati A; Di Giovanni C; Pacilli M; Criniti A
J Cardiovasc Surg (Torino); 1996 Aug; 37(4):401-7. PubMed ID: 8698787
[TBL] [Abstract][Full Text] [Related]
9. Intraoperative Use of Epsilon Amino Caproic Acid and Tranexamic Acid in Surgeries Performed Under Cardiopulmonary Bypass: a Comparative Study To Assess Their Impact On Reopening Due To Postoperative Bleeding.
Choudhuri P; Biswas BK
Ethiop J Health Sci; 2015 Jul; 25(3):273-8. PubMed ID: 26633931
[TBL] [Abstract][Full Text] [Related]
10. Low dose aprotinin and low dose tranexamic acid in elective cardiac surgery with cardiopulmonary bypass.
Waldow T; Krutzsch D; Wils M; Plötze K; Matschke K
Clin Hemorheol Microcirc; 2009; 42(4):269-77. PubMed ID: 19628892
[TBL] [Abstract][Full Text] [Related]
11. Aprotinin versus lysine analogues: the debate continues.
Royston D
Ann Thorac Surg; 1998 Apr; 65(4 Suppl):S9-19; discussion S27-8. PubMed ID: 9563397
[TBL] [Abstract][Full Text] [Related]
12. Increased recombinant activated factor VII use and need for surgical reexploration following a switch from aprotinin to epsilon-aminocaproic acid in infant cardiac surgery.
Scott JP; Costigan DJ; Hoffman GM; Simpson PM; Dasgupta M; Punzalan R; Berens RJ; Tweddell JS; Stuth EA
J Clin Anesth; 2014 May; 26(3):204-11. PubMed ID: 24809789
[TBL] [Abstract][Full Text] [Related]
13. Antifibrinolytics in cardiac surgery.
Dhir A
Ann Card Anaesth; 2013; 16(2):117-25. PubMed ID: 23545866
[TBL] [Abstract][Full Text] [Related]
14. Which may be effective to reduce blood loss after cardiac operations in cyanotic children: tranexamic acid, aprotinin or a combination?
Bulutcu FS; Ozbek U; Polat B; Yalçin Y; Karaci AR; Bayindir O
Paediatr Anaesth; 2005 Jan; 15(1):41-6. PubMed ID: 15649162
[TBL] [Abstract][Full Text] [Related]
15. [Hemostasis and antifibrinolytic therapy in major pediatric surgery].
Schindler E; Hertfelder HJ
Anasthesiol Intensivmed Notfallmed Schmerzther; 2013 Jul; 48(7-8):454-61; quiz 462. PubMed ID: 23929163
[TBL] [Abstract][Full Text] [Related]
16. [Antifibrinolytics and cardiac surgery with cardiopulmonary bypass.].
Santos AT; Splettstosser JC; Warpechowski P; Gaidzinski MM
Rev Bras Anestesiol; 2007 Oct; 57(5):549-64. PubMed ID: 19462132
[TBL] [Abstract][Full Text] [Related]
17. Cost/benefit analysis of pharmacologic hemostasis.
Harmon DE
Ann Thorac Surg; 1996 Feb; 61(2 Suppl):S21-5; discussion S33-4. PubMed ID: 8572828
[TBL] [Abstract][Full Text] [Related]
18. Blood conservation strategies for reducing peri-operative blood loss in open heart surgery.
Rahman Z; Hoque R; Ali A; Rahman M; Rahman MS
Mymensingh Med J; 2011 Jan; 20(1):45-53. PubMed ID: 21240162
[TBL] [Abstract][Full Text] [Related]
19. Can we safely reduce blood loss during lumbar pedicle subtraction osteotomy procedures using tranexamic acid or aprotinin? A comparative study with controls.
Baldus CR; Bridwell KH; Lenke LG; Okubadejo GO
Spine (Phila Pa 1976); 2010 Jan; 35(2):235-9. PubMed ID: 20081519
[TBL] [Abstract][Full Text] [Related]
20. A comparison of aprotinin and lysine analogues in high-risk cardiac surgery.
Fergusson DA; Hébert PC; Mazer CD; Fremes S; MacAdams C; Murkin JM; Teoh K; Duke PC; Arellano R; Blajchman MA; Bussières JS; Côté D; Karski J; Martineau R; Robblee JA; Rodger M; Wells G; Clinch J; Pretorius R;
N Engl J Med; 2008 May; 358(22):2319-31. PubMed ID: 18480196
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
